Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126192531 | 12619253 | 1 | I | 201606 | 20160725 | 20160803 | 20160803 | EXP | GB-MHRA-AMGEN-GBRSP2016077262 | GB-FRESENIUS KABI-FK201604969 | FRESENIUS KABI | 69.00 | YR | F | Y | 0.00000 | 20160803 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126192531 | 12619253 | 1 | PS | ONDANSETRON (MANUFACTURER UNKNOWN) | ONDANSETRON | 1 | Intravenous (not otherwise specified) | U | UNKNOWN | 76972 | 8 | MG | UNKNOWN | ||||||
| 126192531 | 12619253 | 2 | SS | EPIRUBICIN (Manufacturer unknown) | EPIRUBICIN | 1 | Intravenous (not otherwise specified) | U | UNKNOWN | 65411 | 126 | MG | UNKNOWN | ||||||
| 126192531 | 12619253 | 3 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Intravenous (not otherwise specified) | 0 | 9 | MG | UNKNOWN | ||||||||
| 126192531 | 12619253 | 4 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Intravenous (not otherwise specified) | 0 | 8 | MG | UNKNOWN | ||||||||
| 126192531 | 12619253 | 5 | SS | EMEND | APREPITANT | 1 | Oral | 0 | 125 | MG | UNKNOWN | ||||||||
| 126192531 | 12619253 | 6 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | Intravenous (not otherwise specified) | 0 | 1008 | MG | UNKNOWN | ||||||||
| 126192531 | 12619253 | 7 | SS | NEULASTA | PEGFILGRASTIM | 1 | Subcutaneous | 0 | 6 | MG | UNKNOWN |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126192531 | 12619253 | 1 | Product used for unknown indication |
| 126192531 | 12619253 | 2 | Product used for unknown indication |
| 126192531 | 12619253 | 3 | Product used for unknown indication |
| 126192531 | 12619253 | 4 | Product used for unknown indication |
| 126192531 | 12619253 | 5 | Product used for unknown indication |
| 126192531 | 12619253 | 6 | Product used for unknown indication |
| 126192531 | 12619253 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126192531 | 12619253 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126192531 | 12619253 | Alopecia | |
| 126192531 | 12619253 | Body temperature abnormal | |
| 126192531 | 12619253 | Cough | |
| 126192531 | 12619253 | Diarrhoea | |
| 126192531 | 12619253 | Dyspnoea | |
| 126192531 | 12619253 | Ear pain | |
| 126192531 | 12619253 | Eating disorder | |
| 126192531 | 12619253 | Fatigue | |
| 126192531 | 12619253 | Feeling abnormal | |
| 126192531 | 12619253 | Glossodynia | |
| 126192531 | 12619253 | Headache | |
| 126192531 | 12619253 | Hypophagia | |
| 126192531 | 12619253 | Intercepted drug administration error | |
| 126192531 | 12619253 | Lethargy | |
| 126192531 | 12619253 | Lower respiratory tract infection | |
| 126192531 | 12619253 | Malaise | |
| 126192531 | 12619253 | Nausea | |
| 126192531 | 12619253 | Odynophagia | |
| 126192531 | 12619253 | Oral pain | |
| 126192531 | 12619253 | Oropharyngeal pain | |
| 126192531 | 12619253 | Pharyngeal erythema | |
| 126192531 | 12619253 | Productive cough | |
| 126192531 | 12619253 | Sputum discoloured | |
| 126192531 | 12619253 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126192531 | 12619253 | 2 | 20160608 | 0 | ||
| 126192531 | 12619253 | 3 | 20160608 | 0 | ||
| 126192531 | 12619253 | 6 | 20160608 | 0 |